EUVIMEDEUVIMED entdecken
ValidierungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire

Q Oort, J C Reijneveld, S A M Sikkes, J A F Koekkoek, F Boele, T Young, C Brannan, T Chalk, A Talacchi, A Mazzotta, Y Narita, H Sato und 22 weitere

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2024.114335 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Q Oort und 33 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University…. Hauptthemen laut MEDLINE: Activities of Daily Living, Brain Neoplasms, Psychometrics, Quality of Life. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Organisation for Research and Treatment of Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Neurocognitive impairments are common in patients with a brain tumour, and may negatively impact on functioning in daily life, particularly on instrumental activities of daily living (IADL). The EORTC IADL-BN32 questionnaire was developed to measure IADL in this patient population. METHODS: In this international validation study, we evaluated the EORTC IADL-BN32 questionnaire on several psychometric properties in a large sample of patients with a primary or metastatic brain tumour. We administered the 32-item questionnaire three times: at 'baseline', after 2 weeks and after 3 months. Procedures were in accordance with EORTC Quality of Life Group module development guidelines. RESULTS: In total, 326 patients participated in the study. A bifactor scale structure showed satisfactory model fit measures, with five multi-item scales and two single items, and an IADL sum score. The internal consistency of the multi-item scales ranged from good to excellent (range Cronbach's α: 0.86-0.97). We found significant differences in scale scores between patients with and without neurocognitive impairments or complaints, supporting the construct validity. Initial cross-cultural validity analyses showed indications of item response biases for certain items. Analyses indicated moderate to good test-retest agreement (intraclass correlation coefficient > 0.70) between baseline and the 2-week follow-up assessment for all but one scale. Deterioration of EORTC IADL-BN32 scale scores were consistent with clinically relevant deterioration on other functional measures with small to large effect sizes, however, subgroup sample sizes were small. CONCLUSION: Overall, the EORTC IADL-BN32 questionnaire exhibited adequate to excellent psychometric properties. Cross-cultural validity and responsiveness should be further explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activities of Daily LivingBrain NeoplasmsPsychometricsQuality of LifeHumansMaleFemaleSurveys and QuestionnairesMiddle AgedAgedReproducibility of ResultsAdultAged, 80 and over

Stichwörter der Autor:innen

Brain metastasisBrain tumourDaily functioningGliomaIADLInstrumental activities of daily living

Autor:innen und Institutionen

  • Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Centers (Location VUmc), Amsterdam, the Netherlands.
  • Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Centers (Location VUmc), Amsterdam, the Netherlands; Departme…
  • Alzheimer Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Vrije Universiteit Amsterdam, Faculty of Behavioural and Movement Sciences (FGB), Department of Clinical Developmental & Clinica…
  • Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
  • Leeds Institute of Medical Research, St James's University Hospital, Leeds LS9 7TF, United Kingdom; Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom.
  • East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, United Kingdom.

Förderung

  • European Organisation for Research and Treatment of Cancer

Zitieren

APA

Oort, Q., Reijneveld, J. C., Sikkes, S. A. M., Koekkoek, J. A. F., Boele, F., Young, T., Brannan, C., Chalk, T., Talacchi, A., Mazzotta, A., Narita, Y., Sato, H., Miyakita, Y., Shamieh, O., Alrjoob, W., Pace, A., Petranovic, D., Ploh, M., Capela, A., …, & EORTC Quality of Life Group and the EORTC Brain Tumor Group (2024). Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114335

Vancouver

Oort Q, Reijneveld JC, Sikkes SAM, Koekkoek JAF, Boele F, Young T, et al. Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114335

BibTeX
@article{Oort2024,
  author = {Oort, Q and Reijneveld, J C and Sikkes, S A M and Koekkoek, J A F and Boele, F and Young, T and Brannan, C and Chalk, T and Talacchi, A and Mazzotta, A and Narita, Y and Sato, H and Miyakita, Y and Shamieh, O and Alrjoob, W and Pace, A and Petranovic, D and Ploh, M and Capela, A and Silva, J and Hjermstad, M J and Purkart, T Urbanic and Seidel, C and Talhi, N and Pichler, J and Höllmüller, I and Brown, L and Hand, M and Klein, M and Aaronson, N K and Uitdehaag, B M J and Taphoorn, M J B and Dirven, L and EORTC Quality of Life Group and the EORTC Brain Tumor Group, EORTC Quality of Life Group and the EORTC Brain Tumor Group},
  title = {Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2024.114335}
}
Kostenlos starten →